Three facts that shape care for prediabetes
Prediabetes is a warning with a deadline, and three facts shape how men’s care is planned around it. First, it is defined by numbers. The NIDDK puts it at an A1c of 5.7% to 6.4% or a fasting glucose of 100 to 125 mg/dL, so progress can be measured rather than guessed. Second, a modest, specific amount of weight loss changes the odds. Third, in men, low testosterone and rising blood sugar often show up together, so checking one without the other can miss half the picture.
That turns the plan into something closer to a project than a general instruction to “eat better.” There is a starting score, a target, a check-in date and a second marker that might change the approach. Our page on insulin resistance in men explains what is happening underneath the numbers.
The scorecard: A1c and fasting insulin
Two numbers, measured at baseline and again at three months, keep score. A1c reflects your average blood sugar over the past two to three months, according to MedlinePlus, which makes three months the natural point to see whether the plan is working. Fasting insulin shows how hard your pancreas is working to keep that sugar in range.
| Marker | What it tells you | Baseline | Three months |
|---|---|---|---|
| A1c | Average blood sugar over two to three months | Confirms prediabetes and sets the starting score | Shows whether the trend has turned |
| Fasting insulin | How much insulin it takes to hold glucose steady | High values point to insulin resistance | A falling value suggests the body is responding |
| Fasting glucose | Blood sugar at a single moment | Supports the diagnosis | Tracks with A1c |
| Weight and waist | The main lever | Starting point for the 5 to 7 percent target | Progress toward it |
Fasting insulin has no single agreed normal range. MedlinePlus notes that reference ranges can vary between laboratories and that the test usually needs an 8 to 12 hour fast, so the useful comparison is your own result over time, drawn the same way at the same lab. Combined with glucose, it can be turned into a HOMA-IR score, and our page on the fasting insulin test explains how to read it.
The 5 to 7 percent target
The weight-loss goal comes straight from the research. In the Diabetes Prevention Program, more than 3,000 adults with raised blood sugar were assigned to a lifestyle program aiming for at least 7 percent weight loss and 150 minutes of activity a week, to metformin, or to placebo. Over about 2.8 years, the lifestyle program cut new diabetes by 58 percent and metformin by 31 percent compared with placebo. The NIDDK summarizes the practical target as losing 5 to 7 percent of starting weight.
For a 240-pound man, that is roughly 12 to 17 pounds. That number is achievable, and it is the right first milestone even if your longer-term goal is larger. Hitting it by the three-month recheck is a strong sign the plan suits you.
Some men need more help than diet and activity alone. GLP-1 medicines such as semaglutide can be part of the plan, but prediabetes by itself does not decide eligibility. The Wegovy label covers adults with a BMI of 30 or more, or 27 or more with a weight-related condition, alongside diet and exercise. Our answer on whether semaglutide can reverse prediabetes covers what to expect.
Why testosterone is checked too
Testosterone is part of the workup because the two problems are linked. The T4DM trial noted that men with overweight or obesity often have low testosterone, which is associated with a higher risk of type 2 diabetes. In that trial, 1,007 men aged 50 to 74 with a large waist, low-normal testosterone and impaired glucose tolerance or newly diagnosed diabetes all joined a lifestyle program. After two years, 12 percent of men on testosterone had diabetic-range glucose tests, against 21 percent on placebo.
That result needs careful reading. The men did not have classic hypogonadism, and testosterone treatment came with trade-offs: hematocrit rose above 54 percent in 22 percent of the testosterone group, compared with 1 percent on placebo. Testosterone therapy is not a diabetes-prevention drug, and it is considered only for men with confirmed low levels and symptoms. What the trial does show is why a morning testosterone belongs in the baseline. Our answer on whether TRT can reverse prediabetes goes further.
Weight loss itself often raises testosterone, so a borderline result is usually rechecked after the first stretch of weight loss rather than treated straight away.
Monitoring and what to ask
After the three-month recheck, the plan is adjusted to the scorecard. If A1c and fasting insulin are falling and weight is moving toward the target, you keep going. If not, the provider looks at why: food, activity, sleep, medicines that raise blood sugar, or the need for medication support. Once you are back in the normal range, checks space out.
Questions to ask at your first visit
- What are my starting A1c, fasting glucose and fasting insulin, and what would count as progress at three months?
- What is my personal 5 to 7 percent target in pounds?
- Am I eligible for a GLP-1 medicine, and would it help in my case?
- Is my testosterone low, and should it be rechecked after weight loss?
Very high blood sugar can cause extreme thirst, frequent urination, confusion or vomiting. If you have those symptoms, seek same-day care, and call 911 for confusion, fainting or trouble breathing.
Prediabetes care at Ultimate Male
Care starts with a free 10-minute call and a same-day fasting draw at our San Gabriel or Downey clinic, with results in 24 to 48 hours. A PA-C or MD sets your scorecard and target with you, checks your testosterone and explains whether medication fits. A consultation is an evaluation, so the plan may be lifestyle first with a recheck at three months.
If your A1c is already in the diabetic range, our page for men with type 2 diabetes is the better guide. The full program, including labs, body composition and regular check-ins, is on our medical weight loss page.
